Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-08

Clinical Trial Update: Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB) [NA]

View source ↗

Summary

The OPTIMUS-SAB trial is an ongoing study aiming to optimize management of Staphylococcus aureus bacteremia and is currently recruiting at the University of Alb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Staph Aureus Bacteremia | NA | Status: RECRUITING